Dr. Elyse I. Harris, MD
Hematology & Oncology (Hematology & Oncology Physician)
- Medicare participating
At a glance
- Medical school
- University of Texas Medical School at Houston (2015)
- Years since graduation
- 11
- In the NPI registry since
- 2015
- Medicare patients seen, 2024
- 430
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2015Medical school: University of Texas Medical School at Houston
- 2015Registered with an NPI (national billing number; not a license date)
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Hematology & Oncology Physician primary
WI license 70806 -
Internal Medicine Physician
OH license 57.026708 - Student in an Organized Health Care Education/Training Program
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- University of Wi Hospitals & Clinics Authority Madison, WI
- Unitypoint Health - Meriter Madison, WI
- Uw Health Rockford, IL
- Fort Memorial Hospital Fort Atkinson, WI
- Watertown Memorial Hospital Watertown, WI
Medical groups
- University of Wisconsin Medical Foundation Inc (2,553 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 430
- Services billed
- 100,114
- Patients’ average age
- 74
| Service | Times | Patients |
|---|---|---|
| Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 16,830 | 14 |
| Injection, fosaprepitant, 1 mg | 4,350 | 14 |
| Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg | 2,545 | 12 |
| Established patient office or other outpatient visit, 40-54 minutes | 458 | 195 |
| Insertion of needle into vein for collection of blood sample | 418 | 117 |
| Injection of drug or substance under skin or into muscle | 208 | 49 |
| Injection, dexamethasone sodium phosphate, 1 mg | 186 | 12 |
| Injection, zoledronic acid, 1 mg | 184 | 22 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 170 | 31 |
| Administration of chemotherapy into vein, 1 hour or less | 156 | 72 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.